摘要
目的:观察低分子肝素与尿激酶静脉溶栓联合治疗急性心肌梗死的疗效。方法:收治急性心肌梗死患者82例,随机平分两组。入院后均进行常规对症治疗,对照组在此基础上使用低分子肝素治疗,研究组在对照组基础上加用尿激酶静脉溶栓治疗;两组均连续治疗10 d。观察两组临床治疗效果、治疗后4周并发症发生情况及死亡率。结果:研究组临床治疗总有效率85.37%,明显高于对照组的58.54%(P<0.05);研究组并发症总发生率12.20%,明显低于对照组的39.02%(P<0.05);研究组死亡率7.32%,明显低于对照组的24.39%(P<0.05)。结论:低分子肝素与尿激酶静脉溶栓联合治疗急性心肌梗死临床疗效显著,安全性高。
Objective:To observe the efficacy of low molecular heparin combined with intravenous thrombolysis with urokinase in the treatment of acute myocardial infarction.Methods:82 patients with acute myocardial infarction were selected.They were randomly divided into the two groups on average.All patients received routine symptomatic treatment after admission.The control group was treated with low molecular weight heparin on this basis,while patients in the study group were treated with intravenous thrombolysis with urokinase on the basis of the control group.The two groups were all treated for 10 d continuously.The clinical treatment effect,complications and mortality after 4 weeks of treatment were observed in the two groups.Results:The total effective rate of clinical treatment in the study group was 85.37%,which was significantly higher than that of the control group(58.54%)(P<0.05);the total incidence of complications in the study group was 12.20%,which was significantly lower than that of the control group 39.02%(P<0.05);the mortality rate of the study group was 7.32%,which was significantly lower than that of the control group(24.39%)(P<0.05).Conclusion:The clinical curative effect of low molecular heparin combined with intravenous thrombolysis with urokinase in the treatment of acute myocardial infarction is remarkable,with high safety.
出处
《中国社区医师》
2018年第3期10-11,共2页
Chinese Community Doctors
关键词
低分子肝素
尿激酶
急性心肌梗死
Low molecular weight heparin
Urokinase
Acute myocardial infarction
